Summary
Elevance Health, Inc. (formerly Anthem, Inc.) filed this 8-K on September 12, 2018, to disclose information that would be discussed by company officers during investor meetings from September 12 to September 28, 2018. The primary focus of this disclosure is the reaffirmation of the company's full-year 2018 net income guidance. Specifically, Elevance Health expects its full-year 2018 net income to be greater than $14.20 per share. This guidance includes an estimated $1.20 per share in unfavorable items. Excluding these specific items, the company reiterated its expectation for adjusted net income to exceed $15.40 per share. This outlook does not incorporate any additional adjustment items beyond those previously reported in the second quarter of 2018 earnings release.
Key Highlights
- 1Elevance Health (Anthem, Inc.) reaffirmed its full-year 2018 net income guidance.
- 2The company expects full-year 2018 net income to be greater than $14.20 per share.
- 3Unfavorable items are estimated to impact net income by approximately $1.20 per share for the full year 2018.
- 4Excluding these unfavorable items, adjusted net income is projected to be greater than $15.40 per share for 2018.
- 5This guidance excludes any new adjustment items not previously disclosed in the Q2 2018 earnings release.
- 6The disclosure was made in anticipation of investor meetings scheduled between September 12 and September 28, 2018.
- 7The filing emphasizes forward-looking statements and associated risks and uncertainties.